Back to Search
Start Over
Multicenter clinical experience with an atrial lead designed to minimize far-field R-wave sensing.
- Source :
-
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology [Europace] 2009 May; Vol. 11 (5), pp. 618-24. Date of Electronic Publication: 2009 Apr 10. - Publication Year :
- 2009
-
Abstract
- Aims: To evaluate a novel atrial lead designed to reduce far-field sensing.<br />Methods and Results: Sixty-three patients with standard pacing indications were randomized to receive an OptiSense 1699T (St Jude Medical, USA) or conventional pacing lead in the right atrium. Post-implant follow-up was conducted for all patients at 90 days and for a subset at 360 days. Standard electrical parameters were measured. Thresholds of sensing were determined for far-field ventricular signals. The number of inappropriate mode switches was determined from the stored intracardiac electrogram (IEGM). At 90 days, an IEGM Holter recorded 24 h of IEGM. With atrial sensitivity programmed at 0.3 mV, no far-field sensing occurred in the OptiSense group, but it did occur in 20% and 30% of the control group at 90 and 360 days, respectively. Inappropriate mode switching was observed in 4% of the OptiSense group in contrast to 23% of the control group. The IEGM Holter found no far-field sensing in the OptiSense group, but did find 83 023 far-field events from 22% of control patients. The standard electrical parameters of the OptiSense leads were acceptable.<br />Conclusion: The OptiSense lead reduced ventricular far-field sensing in the atrium while maintaining satisfactory pacing and sensing performance, resulting in less inappropriate mode switch.
- Subjects :
- Aged
Aged, 80 and over
Atrial Fibrillation physiopathology
Electrocardiography, Ambulatory
Equipment Design
Female
Foreign-Body Migration
Humans
Male
Middle Aged
Sensitivity and Specificity
Atrial Fibrillation therapy
Electrocardiography
Heart Atria physiopathology
Pacemaker, Artificial adverse effects
Subjects
Details
- Language :
- English
- ISSN :
- 1532-2092
- Volume :
- 11
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
- Publication Type :
- Academic Journal
- Accession number :
- 19363053
- Full Text :
- https://doi.org/10.1093/europace/eup078